Midas Management’s Synchrony SYF Stock Holding History

Midas Management’s Portfolio SYF Stock Details SYF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-65,000	Closed	-$2.02M	–	132
2018 Q3	$2.02M	Hold	65,000	–	–	0.9%	58
2018 Q2	$2.17M	Hold	65,000	–	–	1.03%	49
2018 Q1	$2.18M	Hold	65,000	–	–	1.02%	50
2017 Q4	$2.51M	Hold	65,000	–	–	1%	45
2017 Q3	$2.02M	Buy	+65,000	New	+$1.94M	1.06%	40

Other funds holding SYF

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Midas Management's SYF Position: Q4 2018 in Review

Midas Management sold out of Synchrony (SYF) in Q4 2018, closing a stake of 65,000 shares — an estimated $2.02M sold.

Midas Management first reported a position in SYF in Q3 2017 and held it in 5 quarters. The position peaked at $2.51M in Q4 2017. 674 funds tracked by Wall St. Rank hold SYF as of Q4 2018.

Midas Management reported no remaining Synchrony position as of Q4 2018 after selling out during the quarter.
Midas Management sold 65,000 Synchrony shares in Q4 2018, an estimated $2.02M.
Midas Management first reported a position in Synchrony in Q3 2017 and held it in 5 quarters.
Midas Management's Synchrony position peaked at $2.51M in Q4 2017.
674 funds tracked by Wall St. Rank held Synchrony as of Q4 2018.

Based on Midas Management's 13F filing for Q4 2018, filed 22 Jan 2019.